219 related articles for article (PubMed ID: 26923095)
21. Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
Faisal FA; Sundi D; Pierorazio PM; Ball MW; Humphreys EB; Han M; Epstein JI; Partin AW; Carter HB; Bivalacqua TJ; Schaeffer EM; Ross AE
BJU Int; 2014 Dec; 114(6b):E120-E129. PubMed ID: 24731026
[TBL] [Abstract][Full Text] [Related]
22. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
23. Gleason inflation 1998-2011: a registry study of 97,168 men.
Danneman D; Drevin L; Robinson D; Stattin P; Egevad L
BJU Int; 2015 Feb; 115(2):248-55. PubMed ID: 24552193
[TBL] [Abstract][Full Text] [Related]
24. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
25. Differences in the aggressiveness of prostate cancer among Korean, Caucasian, and African American men: A retrospective cohort study of radical prostatectomy.
Jeong IG; Dajani D; Verghese M; Hwang J; Cho YM; Hong JH; Kim CS; Ahn H; Ro JY
Urol Oncol; 2016 Jan; 34(1):3.e9-14. PubMed ID: 26345648
[TBL] [Abstract][Full Text] [Related]
26. Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
BJU Int; 2018 Feb; 121(2):209-216. PubMed ID: 28418195
[TBL] [Abstract][Full Text] [Related]
27. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
[TBL] [Abstract][Full Text] [Related]
28. Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
Stattin P; Vickers AJ; Sjoberg DD; Johansson R; Granfors T; Johansson M; Pettersson K; Scardino PT; Hallmans G; Lilja H
Eur Urol; 2015 Aug; 68(2):207-13. PubMed ID: 25682340
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Role of Preoperative Serum Lipid Levels in Patients Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer.
Wettstein MS; Saba K; Umbehr MH; Murtola TJ; Fankhauser CD; Adank JP; Hofmann M; Sulser T; Hermanns T; Moch H; Wild P; Poyet C
Prostate; 2017 Apr; 77(5):549-556. PubMed ID: 28093792
[TBL] [Abstract][Full Text] [Related]
30. Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.
Macleod LC; Chery LJ; Hu EY; Zeliadt SB; Holt SK; Lin DW; Porter MP; Gore JL; Wright JL
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):190-5. PubMed ID: 25823651
[TBL] [Abstract][Full Text] [Related]
31. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
32. The risk of prostate cancer for men on aspirin, statin or antidiabetic medications.
Nordström T; Clements M; Karlsson R; Adolfsson J; Grönberg H
Eur J Cancer; 2015 Apr; 51(6):725-33. PubMed ID: 25727881
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Syndrome Components are Associated with Increased Prostate Cancer Risk.
Zhang JQ; Geng H; Ma M; Nan XY; Sheng BW
Med Sci Monit; 2015 Aug; 21():2387-96. PubMed ID: 26275075
[TBL] [Abstract][Full Text] [Related]
34. Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohort.
Essén A; Santaolalla A; Garmo H; Hammar N; Walldius G; Jungner I; Malmström H; Holmberg L; Van Hemelrijck M
Cancer Causes Control; 2019 Jun; 30(6):603-615. PubMed ID: 31020446
[TBL] [Abstract][Full Text] [Related]
35. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study.
Stattin P; Sandin F; Thomsen FB; Garmo H; Robinson D; Lissbrant IF; Jonsson H; Bratt O
Eur Urol; 2017 Jul; 72(1):125-134. PubMed ID: 27481175
[TBL] [Abstract][Full Text] [Related]
36. Clinical, haemodynamic, anthropometric, metabolic and insulin profile of men with high-stage and high-grade clinical prostate cancer.
Hammarsten J; Högstedt B
Blood Press; 2004; 13(1):47-55. PubMed ID: 15083641
[TBL] [Abstract][Full Text] [Related]
37. Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.
Tulloch-Reid MK; McFarlane-Anderson N; Bennett FI; Aiken WD; Jackson MD
Cancer Causes Control; 2017 Nov; 28(11):1313-1321. PubMed ID: 28864928
[TBL] [Abstract][Full Text] [Related]
38. Identification of a novel non-invasive biological marker to overcome the shortcomings of PSA in diagnosis and risk stratification for prostate cancer: Initial prospective study of developmental endothelial locus-1 protein.
Chung JW; Kim HT; Ha YS; Lee EH; Chun SY; Lee CH; Byeon KH; Choi SH; Lee JN; Kim BS; Kim TH; Yoo ES; Yoon GS; Baek MC; Kwon TG
PLoS One; 2021; 16(4):e0250254. PubMed ID: 33901217
[TBL] [Abstract][Full Text] [Related]
39. Risk of localized and advanced prostate cancer among immigrants versus native-born Swedish men: a nation-wide population-based study.
Loeb S; Drevin L; Robinson D; Holmberg E; Carlsson S; Lambe M; Stattin P
Cancer Causes Control; 2013 Feb; 24(2):383-90. PubMed ID: 23266834
[TBL] [Abstract][Full Text] [Related]
40. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Morote J; Celma A; Planas J; Placer J; de Torres I; Olivan M; Carles J; Reventós J; Doll A
Int J Mol Sci; 2014 Aug; 15(8):13615-23. PubMed ID: 25101846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
